Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,144.00
(
0.54%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.64
(
2.38%
)
Bitcoin
74,818.03
(
-0.03%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biopearl post# 4732

Wednesday, 08/22/2007 7:24:42 PM

Wednesday, August 22, 2007 7:24:42 PM

Post# of 19309
>If I read the previous studies re Atryn it looks like there is no effect on circulating protein C but there is with thrombomodulin. Can you help me understand how that difference might play out?<

Antithrombin inhibits a separate thrombin feedback loop from the thrombin feedback loop inhibited by thrombomodulin, which acts on protein C. Thus, it’s not a concern that antithrombin does not affect protein C—it’s not supposed to.

Let’s talk more about these technical matters after I’ve distributed the ART-123 paper. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now